In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction

Intrauterine growth restriction (IUGR) is strongly associated with obesity in adult life. The mechanisms contributing to the onset of IUGR-associated adult obesity have been studied in animal models and humans, where changes in fetal adipose tissue development, hormone levels and epigenome have been...

Full description

Saved in:
Bibliographic Details
Main Authors: Ousseynou Sarr, Kaiping Yang, Timothy R. H. Regnault
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Pregnancy
Online Access:http://dx.doi.org/10.1155/2012/134758
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850174484864040960
author Ousseynou Sarr
Kaiping Yang
Timothy R. H. Regnault
author_facet Ousseynou Sarr
Kaiping Yang
Timothy R. H. Regnault
author_sort Ousseynou Sarr
collection DOAJ
description Intrauterine growth restriction (IUGR) is strongly associated with obesity in adult life. The mechanisms contributing to the onset of IUGR-associated adult obesity have been studied in animal models and humans, where changes in fetal adipose tissue development, hormone levels and epigenome have been identified as principal areas of alteration leading to later life obesity. Following an adverse in utero development, IUGR fetuses display increased lipogenic and adipogenic capacity in adipocytes, hypoleptinemia, altered glucocorticoid signalling, and chromatin remodelling, which subsequently all contribute to an increased later life obesity risk. Data suggest that many of these changes result from an enhanced activity of the adipose master transcription factor regulator, peroxisome proliferator-activated receptor-γ (PPARγ) and its coregulators, increased lipogenic fatty acid synthase (FAS) expression and activity, and upregulation of glycolysis in fetal adipose tissue. Increased expression of fetal hypothalamic neuropeptide Y (NPY), altered hypothalamic leptin receptor expression and partitioning, reduced adipose noradrenergic sympathetic innervations, enhanced adipose glucocorticoid action, and modifications in methylation status in the promoter of hepatic and adipose adipogenic and lipogenic genes in the fetus also contribute to obesity following IUGR. Therefore, interventions that inhibit these fetal developmental changes will be beneficial for modulation of adult body fat accumulation.
format Article
id doaj-art-d5c919a7b56d420f88bfb5d3ca436a18
institution OA Journals
issn 2090-2727
2090-2735
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Pregnancy
spelling doaj-art-d5c919a7b56d420f88bfb5d3ca436a182025-08-20T02:19:38ZengWileyJournal of Pregnancy2090-27272090-27352012-01-01201210.1155/2012/134758134758In Utero Programming of Later Adiposity: The Role of Fetal Growth RestrictionOusseynou Sarr0Kaiping Yang1Timothy R. H. Regnault2Department of Obstetrics and Gynaecology, Children's Health Research Institute and Lawson Research Institute, University of Western Ontario, 1151 Richmond Street, London, ON, N6A 5C1, CanadaDepartment of Obstetrics and Gynaecology, Children's Health Research Institute and Lawson Research Institute, University of Western Ontario, 1151 Richmond Street, London, ON, N6A 5C1, CanadaDepartment of Obstetrics and Gynaecology, Children's Health Research Institute and Lawson Research Institute, University of Western Ontario, 1151 Richmond Street, London, ON, N6A 5C1, CanadaIntrauterine growth restriction (IUGR) is strongly associated with obesity in adult life. The mechanisms contributing to the onset of IUGR-associated adult obesity have been studied in animal models and humans, where changes in fetal adipose tissue development, hormone levels and epigenome have been identified as principal areas of alteration leading to later life obesity. Following an adverse in utero development, IUGR fetuses display increased lipogenic and adipogenic capacity in adipocytes, hypoleptinemia, altered glucocorticoid signalling, and chromatin remodelling, which subsequently all contribute to an increased later life obesity risk. Data suggest that many of these changes result from an enhanced activity of the adipose master transcription factor regulator, peroxisome proliferator-activated receptor-γ (PPARγ) and its coregulators, increased lipogenic fatty acid synthase (FAS) expression and activity, and upregulation of glycolysis in fetal adipose tissue. Increased expression of fetal hypothalamic neuropeptide Y (NPY), altered hypothalamic leptin receptor expression and partitioning, reduced adipose noradrenergic sympathetic innervations, enhanced adipose glucocorticoid action, and modifications in methylation status in the promoter of hepatic and adipose adipogenic and lipogenic genes in the fetus also contribute to obesity following IUGR. Therefore, interventions that inhibit these fetal developmental changes will be beneficial for modulation of adult body fat accumulation.http://dx.doi.org/10.1155/2012/134758
spellingShingle Ousseynou Sarr
Kaiping Yang
Timothy R. H. Regnault
In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
Journal of Pregnancy
title In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
title_full In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
title_fullStr In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
title_full_unstemmed In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
title_short In Utero Programming of Later Adiposity: The Role of Fetal Growth Restriction
title_sort in utero programming of later adiposity the role of fetal growth restriction
url http://dx.doi.org/10.1155/2012/134758
work_keys_str_mv AT ousseynousarr inuteroprogrammingoflateradipositytheroleoffetalgrowthrestriction
AT kaipingyang inuteroprogrammingoflateradipositytheroleoffetalgrowthrestriction
AT timothyrhregnault inuteroprogrammingoflateradipositytheroleoffetalgrowthrestriction